Safety, regulatory, quality and commercial compliance have long been regarded as cost-centers and mandated necessities - but leading organizations are recognizing opportunities for innovation and growth in these areas. This paper addresses how a proactive approach and innovation are vital to comply with the ever changing regulatory requirements and take on the future.
A recent global survey of pharmaceutical CEOs shows an increase in regulatory scrutiny across many aspects of the business, including sales and marketing practices, government drug price reporting, data privacy management, and clinical operations. Changes in industry regulations are now viewed as one of the top three disruptive business trends faced by pharmaceutical and life sciences organizations, and many pharma leaders view these changes as a threat to their growth.
But they don’t have to be.
Compliance has long been viewed as a cost-center and a necessity, but leading organizations are recognizing opportunities for innovation in this space.